Swiss Life Asset Management’s Veracyte VCYT Stock Holding History

Swiss Life Asset Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$462K	Buy	+7,864	New	+$330K	﹤0.01%	1008

Other funds holding VCYT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Swiss Life Asset Management's VCYT Position: Q2 2026 in Review

Swiss Life Asset Management opened a new position in Veracyte (VCYT) in Q2 2026: 7,864 shares worth $462K. The stake represents ﹤0.01% of the portfolio and ranks #1008 among its holdings.

264 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

Swiss Life Asset Management held 7,864 shares of Veracyte worth $462K as of Q2 2026.
Veracyte was a new Swiss Life Asset Management position in Q2 2026.
Veracyte made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #1008 holding.
264 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.